Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy
For adeno‐associated virus (AAV)‐based human gene therapy, challenges for the translation of promising research results to successful clinical development include optimization of vector design and manufacturing processes to ensure that vectors prepared for administration to human subjects have attri...
Gespeichert in:
| Veröffentlicht in: | Biotechnology journal 2021-01, Vol.16 (1), p.e2000022-n/a |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 1 |
| container_start_page | e2000022 |
| container_title | Biotechnology journal |
| container_volume | 16 |
| creator | Wright, J. Fraser |
| description | For adeno‐associated virus (AAV)‐based human gene therapy, challenges for the translation of promising research results to successful clinical development include optimization of vector design and manufacturing processes to ensure that vectors prepared for administration to human subjects have attributes consistent with safe and durable expression. This article briefly reviews quality control methods for routine testing and supplemental characterization of AAV vectors for investigational product development. The relationship of vector and manufacturing process design with product critical quality attributes is discussed.
This article describes quality control testing and characterization of adeno‐associated virus (AAV) gene therapy vectors for clinical product development. It explores the relationship between AAV vector design and manufacturing process design with product critical quality attributes required for safety and durable efficacious expression, with emphasis on vector immunogenicity. |
| doi_str_mv | 10.1002/biot.202000022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2457677123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2457677123</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3452-8401321c6842fa783da8e93c3f34b35bc8b242da224ea2b8f1c519caeac152d13</originalsourceid><addsrcrecordid>eNqFkDlPw0AQhVcIRLhaSrQlBQl7-UgZLC4JKUJK0lrj9Zgscrxhdy0UKlo6fiO_BKOEUDLNjGa-96R5hJxyNuCMicvC2DAQTLCuhNghBzyNWT-RXO1u5jiJ0x459P6ZMRVJpvZJT3b3eMj5Afl4bKE2YUUz2wRnazpBH0zzdEGzOTjQAZ15g2BsQ6EpaeZMMBpq-isbheBM0Qb01FZ0VGJjv94_R95bbSBgSWfGtZ7OUAfrPJ36blVZR-_aBTT0Fhukkzk6WK6OyV4FtceTTT8i05vrSXbXfxjf3mejh76WKhL9VDEuBddxqkQFSSpLSHEotaykKmRU6LQQSpQghEIQRVpxHfGhBgTNI1FyeUTO175LZ1_a7tt8YbzGuoYGbetzoaIkThIuZIcO1qh21nuHVb50ZgFulXOW_8Sf_8Sfb-PvBGcb77ZYYLnFf_PugOEaeDU1rv6xy6_ux5M_82-iSJRR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2457677123</pqid></control><display><type>article</type><title>Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wright, J. Fraser</creator><creatorcontrib>Wright, J. Fraser</creatorcontrib><description>For adeno‐associated virus (AAV)‐based human gene therapy, challenges for the translation of promising research results to successful clinical development include optimization of vector design and manufacturing processes to ensure that vectors prepared for administration to human subjects have attributes consistent with safe and durable expression. This article briefly reviews quality control methods for routine testing and supplemental characterization of AAV vectors for investigational product development. The relationship of vector and manufacturing process design with product critical quality attributes is discussed.
This article describes quality control testing and characterization of adeno‐associated virus (AAV) gene therapy vectors for clinical product development. It explores the relationship between AAV vector design and manufacturing process design with product critical quality attributes required for safety and durable efficacious expression, with emphasis on vector immunogenicity.</description><identifier>ISSN: 1860-6768</identifier><identifier>EISSN: 1860-7314</identifier><identifier>DOI: 10.1002/biot.202000022</identifier><identifier>PMID: 33146911</identifier><language>eng</language><publisher>Germany</publisher><subject>adeno‐associated viruses ; characterization ; critical quality attributes ; Dependovirus - genetics ; Genetic Therapy ; Genetic Vectors - genetics ; Humans ; Quality Control ; quality controls ; vector design</subject><ispartof>Biotechnology journal, 2021-01, Vol.16 (1), p.e2000022-n/a</ispartof><rights>2020 Wiley‐VCH GmbH</rights><rights>2020 Wiley-VCH GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3452-8401321c6842fa783da8e93c3f34b35bc8b242da224ea2b8f1c519caeac152d13</citedby><cites>FETCH-LOGICAL-c3452-8401321c6842fa783da8e93c3f34b35bc8b242da224ea2b8f1c519caeac152d13</cites><orcidid>0000-0001-9635-1750</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbiot.202000022$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbiot.202000022$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33146911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wright, J. Fraser</creatorcontrib><title>Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy</title><title>Biotechnology journal</title><addtitle>Biotechnol J</addtitle><description>For adeno‐associated virus (AAV)‐based human gene therapy, challenges for the translation of promising research results to successful clinical development include optimization of vector design and manufacturing processes to ensure that vectors prepared for administration to human subjects have attributes consistent with safe and durable expression. This article briefly reviews quality control methods for routine testing and supplemental characterization of AAV vectors for investigational product development. The relationship of vector and manufacturing process design with product critical quality attributes is discussed.
This article describes quality control testing and characterization of adeno‐associated virus (AAV) gene therapy vectors for clinical product development. It explores the relationship between AAV vector design and manufacturing process design with product critical quality attributes required for safety and durable efficacious expression, with emphasis on vector immunogenicity.</description><subject>adeno‐associated viruses</subject><subject>characterization</subject><subject>critical quality attributes</subject><subject>Dependovirus - genetics</subject><subject>Genetic Therapy</subject><subject>Genetic Vectors - genetics</subject><subject>Humans</subject><subject>Quality Control</subject><subject>quality controls</subject><subject>vector design</subject><issn>1860-6768</issn><issn>1860-7314</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDlPw0AQhVcIRLhaSrQlBQl7-UgZLC4JKUJK0lrj9Zgscrxhdy0UKlo6fiO_BKOEUDLNjGa-96R5hJxyNuCMicvC2DAQTLCuhNghBzyNWT-RXO1u5jiJ0x459P6ZMRVJpvZJT3b3eMj5Afl4bKE2YUUz2wRnazpBH0zzdEGzOTjQAZ15g2BsQ6EpaeZMMBpq-isbheBM0Qb01FZ0VGJjv94_R95bbSBgSWfGtZ7OUAfrPJ36blVZR-_aBTT0Fhukkzk6WK6OyV4FtceTTT8i05vrSXbXfxjf3mejh76WKhL9VDEuBddxqkQFSSpLSHEotaykKmRU6LQQSpQghEIQRVpxHfGhBgTNI1FyeUTO175LZ1_a7tt8YbzGuoYGbetzoaIkThIuZIcO1qh21nuHVb50ZgFulXOW_8Sf_8Sfb-PvBGcb77ZYYLnFf_PugOEaeDU1rv6xy6_ux5M_82-iSJRR</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Wright, J. Fraser</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9635-1750</orcidid></search><sort><creationdate>202101</creationdate><title>Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy</title><author>Wright, J. Fraser</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3452-8401321c6842fa783da8e93c3f34b35bc8b242da224ea2b8f1c519caeac152d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adeno‐associated viruses</topic><topic>characterization</topic><topic>critical quality attributes</topic><topic>Dependovirus - genetics</topic><topic>Genetic Therapy</topic><topic>Genetic Vectors - genetics</topic><topic>Humans</topic><topic>Quality Control</topic><topic>quality controls</topic><topic>vector design</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wright, J. Fraser</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wright, J. Fraser</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy</atitle><jtitle>Biotechnology journal</jtitle><addtitle>Biotechnol J</addtitle><date>2021-01</date><risdate>2021</risdate><volume>16</volume><issue>1</issue><spage>e2000022</spage><epage>n/a</epage><pages>e2000022-n/a</pages><issn>1860-6768</issn><eissn>1860-7314</eissn><abstract>For adeno‐associated virus (AAV)‐based human gene therapy, challenges for the translation of promising research results to successful clinical development include optimization of vector design and manufacturing processes to ensure that vectors prepared for administration to human subjects have attributes consistent with safe and durable expression. This article briefly reviews quality control methods for routine testing and supplemental characterization of AAV vectors for investigational product development. The relationship of vector and manufacturing process design with product critical quality attributes is discussed.
This article describes quality control testing and characterization of adeno‐associated virus (AAV) gene therapy vectors for clinical product development. It explores the relationship between AAV vector design and manufacturing process design with product critical quality attributes required for safety and durable efficacious expression, with emphasis on vector immunogenicity.</abstract><cop>Germany</cop><pmid>33146911</pmid><doi>10.1002/biot.202000022</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-9635-1750</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1860-6768 |
| ispartof | Biotechnology journal, 2021-01, Vol.16 (1), p.e2000022-n/a |
| issn | 1860-6768 1860-7314 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2457677123 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | adeno‐associated viruses characterization critical quality attributes Dependovirus - genetics Genetic Therapy Genetic Vectors - genetics Humans Quality Control quality controls vector design |
| title | Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quality%20Control%20Testing,%20Characterization%20and%20Critical%20Quality%20Attributes%20of%20Adeno%E2%80%90Associated%20Virus%20Vectors%20Used%20for%20Human%20Gene%20Therapy&rft.jtitle=Biotechnology%20journal&rft.au=Wright,%20J.%20Fraser&rft.date=2021-01&rft.volume=16&rft.issue=1&rft.spage=e2000022&rft.epage=n/a&rft.pages=e2000022-n/a&rft.issn=1860-6768&rft.eissn=1860-7314&rft_id=info:doi/10.1002/biot.202000022&rft_dat=%3Cproquest_cross%3E2457677123%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2457677123&rft_id=info:pmid/33146911&rfr_iscdi=true |